Clinical Trial Update: 12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of adding asenapine to ongoing lithium/valproate therapy in bipolar disorder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Asenapine (asenapine)
• Lithium (Lithium carbonate)
• Valproate (valproate)

Snippet

Sponsor: Organon and Co | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-09-16